The effects on depression are via IDO and Tryptophan-2,3-dioxygenase (TDO), with an increase in Kynurenine (KYN) in the Tryptophan (TRP) metabolic pathway, resulting in a reduced amount of Serotonin. This evidence concerns the gene IDO1 and depressive symptom measurement.